ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Ductal Carcinoma
H. Lee Moffitt Cancer Center and Research Institutegene_therapyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Ductal Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Sanofi | Phase 2 | CCC |
EXEMESTANE Dana-Farber Cancer Institute | Phase 2 | CCC |
TAMOXIFEN Dana-Farber Cancer Institute | Phase 2 | CCC |
Docetaxel Sanofi | Phase 2 | CCC |
Htert University of Pennsylvania | Phase 1 | CC |
View all 10 →
Same molecule, other indications
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →